ProfileGDS5678 / 1443418_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 63% 63% 63% 62% 63% 63% 63% 63% 63% 63% 63% 63% 66% 63% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.7999963
GSM967853U87-EV human glioblastoma xenograft - Control 23.784863
GSM967854U87-EV human glioblastoma xenograft - Control 33.7549463
GSM967855U87-EV human glioblastoma xenograft - Control 43.6863762
GSM967856U87-EV human glioblastoma xenograft - Control 53.708563
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.814163
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.8379763
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.7423763
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.7607263
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.7452463
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.7817163
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.7620263
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.9698266
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.7706263